Editas Medicine Announces Second Quarter 2018 Results and Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- S&P 500, Nasdaq eye tepid open as Middle East tensions weigh
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
- Snowflake soars 20% on earnings beat and raised guidance
Editas Medicine (EDIT) Misses Q2 EPS by 15c
August 6, 2018 4:36 PM EDTEditas Medicine (NASDAQ: EDIT) reported Q2 EPS of ($0.82), $0.15 worse than the analyst estimate of ($0.67). Revenue for the quarter came in at $7.4 million versus the consensus estimate of $6.73 million.
For earnings history and earnings-related data on Editas Medicine (EDIT) click here.
... More